Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms.

Jackson CR, Sriharan A, Vaickus LJ.

Mod Pathol. 2020 Apr 1. doi: 10.1038/s41379-020-0526-z. [Epub ahead of print]

PMID:
32238879
2.

PathFlowAI: A High-Throughput Workflow for Preprocessing, Deep Learning and Interpretation in Digital Pathology.

Levy JJ, Salas LA, Christensen BC, Sriharan A, Vaickus LJ.

Pac Symp Biocomput. 2020;25:403-414.

3.

Pathologist-level classification of histologic patterns on resected lung adenocarcinoma slides with deep neural networks.

Wei JW, Tafe LJ, Linnik YA, Vaickus LJ, Tomita N, Hassanpour S.

Sci Rep. 2019 Mar 4;9(1):3358. doi: 10.1038/s41598-019-40041-7.

4.

Automating the Paris System for urine cytopathology-A hybrid deep-learning and morphometric approach.

Vaickus LJ, Suriawinata AA, Wei JW, Liu X.

Cancer Cytopathol. 2019 Feb;127(2):98-115. doi: 10.1002/cncy.22099. Epub 2019 Jan 31.

5.

Pancreatic mixed acinar-neuroendocrine carcinoma, a unique diagnostic challenge on FNA cytology: A small series of two cases with literature review.

Strait AM, Sharma N, Tsapakos MJ, Vaickus LJ, Liu X.

Diagn Cytopathol. 2018 Nov;46(11):971-976. doi: 10.1002/dc.23981. Epub 2018 Oct 3. Review.

PMID:
30284406
6.

Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases.

Facciponte DN, Bough MW, Seidler D, Carroll JL, Ashare A, Andrew AS, Tsongalis GJ, Vaickus LJ, Henegan PL, Butt TH, Stommel EW.

Sci Total Environ. 2018 Dec 15;645:1003-1013. doi: 10.1016/j.scitotenv.2018.07.226. Epub 2018 Jul 20.

7.

First Human Implantation of a Bioresorbable Polymer Scaffold for Acute Traumatic Spinal Cord Injury: A Clinical Pilot Study for Safety and Feasibility.

Theodore N, Hlubek R, Danielson J, Neff K, Vaickus L, Ulich TR, Ropper AE.

Neurosurgery. 2016 Aug;79(2):E305-12. doi: 10.1227/NEU.0000000000001283.

PMID:
27309344
8.

A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors.

Shimizu T, Fukuoka K, Takeda M, Iwasa T, Yoshida T, Horobin J, Keegan M, Vaickus L, Chavan A, Padval M, Nakagawa K.

Cancer Chemother Pharmacol. 2016 May;77(5):997-1003. doi: 10.1007/s00280-016-3010-1. Epub 2016 Mar 30.

9.

Young investigator challenge: Comparison of 2 different methods of manual slide screening in semiautomated gynecologic cytology.

Vaickus LJ, Wilbur DC, Sweeney BJ, Renshaw AA.

Cancer Cytopathol. 2015 Nov;123(11):650-8. doi: 10.1002/cncy.21581.

10.

Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.

Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M, Pusztaszeri MP, VandenBussche CJ, Gourmaud J, Vaickus LJ, Baloch ZW.

Cancer Cytopathol. 2016 Mar;124(3):181-7. doi: 10.1002/cncy.21631. Epub 2015 Oct 12.

11.

Young investigator challenge: The accuracy of the nuclear-to-cytoplasmic ratio estimation among trained morphologists.

Vaickus LJ, Tambouret RH.

Cancer Cytopathol. 2015 Sep;123(9):524-30. doi: 10.1002/cncy.21585.

12.

A simplified method for assessing cytotechnologist workload.

Vaickus LJ, Tambouret R.

Cancer Cytopathol. 2014 Jan;122(1):15-22. doi: 10.1002/cncy.21364. Epub 2013 Nov 6. Erratum in: Cancer Cytopathol. 2015 Aug;123(8):505.

13.

Chemokines mediate ethanol-induced exacerbations of murine cockroach allergen asthma.

Bouchard JC, Beal DR, Kim J, Vaickus LJ, Remick DG.

Clin Exp Immunol. 2013 May;172(2):203-16. doi: 10.1111/cei.12048.

14.

Cecal ligation and puncture-induced murine sepsis does not cause lung injury.

Iskander KN, Craciun FL, Stepien DM, Duffy ER, Kim J, Moitra R, Vaickus LJ, Osuchowski MF, Remick DG.

Crit Care Med. 2013 Jan;41(1):159-70. doi: 10.1097/CCM.0b013e3182676322.

15.

A2B adenosine receptor expression by myeloid cells is proinflammatory in murine allergic-airway inflammation.

Belikoff BG, Vaickus LJ, Sitkovsky M, Remick DG.

J Immunol. 2012 Oct 1;189(7):3707-13. Epub 2012 Sep 5.

16.

Acute oral ethanol exposure triggers asthma in cockroach allergen-sensitized mice.

Bouchard JC, Kim J, Beal DR, Vaickus LJ, Craciun FL, Remick DG.

Am J Pathol. 2012 Sep;181(3):845-57. doi: 10.1016/j.ajpath.2012.05.020. Epub 2012 Jul 13.

17.

Cockroach allergens induce biphasic asthma-like pulmonary inflammation in outbred mice.

Vaickus LJ, Bouchard J, Kim J, Natarajan S, Remick DG.

J Asthma. 2012 Jun;49(5):510-21. doi: 10.3109/02770903.2012.678958. Epub 2012 Apr 30.

18.

Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines.

Kim J, Natarajan S, Vaickus LJ, Bouchard JC, Beal D, Cruikshank WW, Remick DG.

Am J Pathol. 2011 Dec;179(6):2730-9. doi: 10.1016/j.ajpath.2011.08.008. Epub 2011 Oct 1.

19.

Inbred and outbred mice have equivalent variability in a cockroach allergen-induced model of asthma.

Vaickus LJ, Bouchard J, Kim J, Natarajan S, Remick DG.

Comp Med. 2010 Dec;60(6):420-6.

20.

Oral tolerance inhibits pulmonary eosinophilia in a cockroach allergen induced model of asthma: a randomized laboratory study.

Vaickus LJ, Bouchard J, Kim J, Natarajan S, Remick DG.

Respir Res. 2010 Nov 23;11:160. doi: 10.1186/1465-9921-11-160.

21.

Assessing pulmonary pathology by detailed examination of respiratory function.

Vaickus LJ, Bouchard J, Kim J, Natarajan S, Remick DG.

Am J Pathol. 2010 Oct;177(4):1861-9. doi: 10.2353/ajpath.2010.100053. Epub 2010 Aug 19.

22.

Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody.

Ponte JF, Ponath P, Gulati R, Slavonic M, Paglia M, O'Shea A, Tone M, Waldmann H, Vaickus L, Rosenzweig M.

Immunology. 2010 Jun;130(2):231-42. doi: 10.1111/j.1365-2567.2009.03228.x. Epub 2010 Feb 26.

23.

Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus.

Wiczling P, Rosenzweig M, Vaickus L, Jusko WJ.

J Clin Pharmacol. 2010 May;50(5):494-506. doi: 10.1177/0091270009349376. Epub 2009 Nov 23.

PMID:
19934031
24.

Development of a quantitative assay to measure EBV viral load in patients with autoimmune type 1 diabetes and healthy subjects.

Rosenzweig M, Rosenthal CA, Torres VM, Vaickus L.

J Virol Methods. 2010 Mar;164(1-2):111-5. doi: 10.1016/j.jviromet.2009.11.018. Epub 2009 Nov 18.

PMID:
19931313
25.

Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers.

Ng CM, Stefanich E, Anand BS, Fielder PJ, Vaickus L.

Pharm Res. 2006 Jan;23(1):95-103. Epub 2006 Nov 30.

PMID:
16308668
26.

Levalbuterol hydrochloride.

Handley DA, Morley J, Vaickus L.

Expert Opin Investig Drugs. 1998 Dec;7(12):2027-41.

PMID:
15991945
27.

Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study.

Nowak RM, Emerman CL, Schaefer K, Disantostefano RL, Vaickus L, Roach JM.

Am J Emerg Med. 2004 Jan;22(1):29-36.

PMID:
14724875
28.

Recombinant interleukin-6 in the treatment of congenital thrombocytopenia associated with absent radii.

Aquino VM, Mustafa MM, Vaickus L, Wooley R, Buchanan GR.

J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):474-6.

PMID:
9787323
29.

Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer.

Byhardt RW, Vaickus L, Witt PL, Chang AY, McAuliffe T, Wilson JF, Lawton CA, Breitmeyer J, Alger ME, Borden EC.

J Interferon Cytokine Res. 1996 Nov;16(11):891-902.

PMID:
8938564
30.

Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery.

Meropol NJ, Petrelli NJ, Lipman BJ, Rodriguez-Bigas M, Hicks W, Douglass HO Jr, Smith JL, Rasey M, Blumenson LE, Vaickus L, Hayes FA, Agosti JM.

Am J Surg. 1996 Sep;172(3):299-302.

PMID:
8862090
31.

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.

Meropol NJ, Porter M, Blumenson LE, Lindemann MJ, Perez RP, Vaickus L, Loewen GM, Creaven PJ, Wilkes KA, Giedlin MA, Caligiuri MA.

Clin Cancer Res. 1996 Apr;2(4):669-77.

32.

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.

Foon KA, Oseroff AR, Vaickus L, Greenberg SJ, Russell D, Bernstein Z, Pincus S, Köhler H, Seon BK, Tahaoglu E, et al.

Clin Cancer Res. 1995 Nov;1(11):1285-94.

33.

Platelet transfusion and alternatives to transfusion in patients with malignancy.

Vaickus L, Breitmeyer JB, Schlossman RL, Anderson KC.

Stem Cells. 1995 Nov;13(6):588-96. Review.

PMID:
8590860
34.

Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute.

Wilkes JD, Fidias P, Vaickus L, Perez RP.

Cancer. 1995 Oct 15;76(8):1377-87. Review.

PMID:
8620412
35.

Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.

Ritch PS, Keever C, Schiller J, Rivkin S, Witt PL, Grossberg SE, Truitt RL, Burris H, von Hoff DD, Vaickus L, et al.

Ann N Y Acad Sci. 1995 Jul 21;762:359-60. No abstract available.

PMID:
7668536
36.

Carboplatin for small cell lung cancer: progress toward greater efficacy and reduced toxicity.

Raghavan D, Perez R, Creaven P, Takita H, Loewen G, Vaickus L.

Semin Oncol. 1994 Jun;21(3 Suppl 6):1-8. Review.

PMID:
8052868
37.

Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF)

Vaickus L, Villalona-Calero MA, Caligiuri T.

Leukemia. 1993 Oct;7(10):1680-1. No abstract available.

PMID:
7692195
38.

Antiidiotype (Ab2) vaccine therapy for cutaneous T-cell lymphoma.

Chatterjee M, Mrozek E, Vaickus L, Oseroff A, Stoll H, Russell D, Kohler H, Foon KA.

Ann N Y Acad Sci. 1993 Aug 12;690:376-7. No abstract available.

PMID:
8368761
39.

Renal cell carcinoma treated with continuous-infusion interleukin-2 with ex vivo-activated killer cells.

Foon KA, Walther PJ, Bernstein ZP, Vaickus L, Rahman R, Watanabe H, Sweeney J, Park J, Vesper D, Russell D, et al.

J Immunother (1991). 1992 Apr;11(3):184-90.

PMID:
1515423
40.
41.

Immune markers in hematologic malignancies.

Vaickus L, Ball ED, Foon KA.

Crit Rev Oncol Hematol. 1991 Dec;11(4):267-97. Review.

PMID:
1777090
42.

Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancer.

Bernstein ZP, Goldrosen MH, Vaickus L, Friedman N, Watanabe H, Rahman R, Park J, Arbuck SG, Sweeney J, Vesper DS, et al.

J Immunother (1991). 1991 Oct;10(5):383-7.

PMID:
1665077
43.

Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes.

Cemerlíc D, Dadey B, Han T, Vaickus L.

Blood. 1991 Jun 15;77(12):2707-15.

PMID:
1904285
44.

Unusual gastrointestinal complications of interleukin-2 therapy.

Rahman R, Bernstein Z, Vaickus L, Penetrante R, Arbuck S, Kopec I, Vesper D, Douglass HO Jr, Foon KA.

J Immunother (1991). 1991 Jun;10(3):221-5.

PMID:
1868046
45.

Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease.

Bernstein ZP, Vaickus L, Friedman N, Goldrosen MH, Watanabe H, Rahman R, Arbuck SG, Sweeney J, Vesper D, Henderson ED, et al.

J Immunother (1991). 1991 Apr;10(2):141-6.

PMID:
2043594
46.

Overview of monoclonal antibodies in the diagnosis and therapy of cancer.

Vaickus L, Foon KA.

Cancer Invest. 1991;9(2):195-209. Review.

PMID:
1863875
47.

Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis.

Vaickus L, Biddle W, Cemerlić D, Foon KA.

Blood. 1990 Jun 15;75(12):2408-16.

PMID:
2140949
49.

Nuclear magnetic resonance spectroscopy of plasma for the detection of head and neck cancer.

Dawson DE, Sekhar V, Pearson G, Vaickus L.

Am J Otolaryngol. 1989 Jul-Aug;10(4):244-9.

PMID:
2764236
50.

Antiproliferative mechanism of anti-class II monoclonal antibodies.

Vaickus L, Jones VE, Morton CL, Whitford K, Bacon RN.

Cell Immunol. 1989 Apr 1;119(2):445-58.

PMID:
2702695

Supplemental Content

Loading ...
Support Center